login
login

Europe Daily Bulletin No. 10062

23 January 2010
Contents Publication in full By article 29 / 34
GENERAL NEWS / (eu) eu/medicines

22/01/2010 (Agence Europe) - On Thursday 21 January, the European Medicines Agency (EMEA) recommended that marketing authorisations for weight-loss medicines containing sibutramine be suspended. Analysis of the data from the SCOUT (Sibutramine Cardiovascular Outcome Trail) study revealed that patients treated with this product ran a higher risk of cardiovascular events. Since overweight and obese patients are already at a higher risk of cardiovascular events, the EMEA decided it would be...

Contents

SNIPPETS
THE DAY IN POLITICS
GENERAL NEWS
CALENDAR OF EVENTS